BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Afimetoran readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Afimetoran\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07881120-5538@assetmemo.bio
DTSTAMP:20261121T005654Z
DTSTART;VALUE=DATE:20300430
DTEND;VALUE=DATE:20300501
SUMMARY:Afimetoran: Phase 2/3 readout est. (NCT07881120)
DESCRIPTION:Afimetoran\, phase 2/3.\nStudy: Study of Afimetoran in Adults W
 ith Cutaneous Lupus Erythematosus\nEstimated primary completion: April 203
 0. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, 
 and it can move.\nDrug page: https://assetmemo.bio/drug/afimetoran#upcomin
 g-events\nRegistry record: https://clinicaltrials.gov/study/NCT07881120
URL:https://assetmemo.bio/drug/afimetoran#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
